Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Dexlansoprazole
Takeda
Laryngo-pharyngeal Reflux
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Benign Neoplasm of Vocal Fold - Glottis
1 trial -
Dihydroartemisinin piperaquine
United Therapeutics Europe Ltd
Malaria
1 trial -
Docetaxel
The First People's Hospital of Lianyungang
Esophageal Neoplasms
1 trial -
Drug treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Prolactinoma
1 trial -
Drugs and Stimulation
The First People's Hospital of Lianyungang
Hearing Loss, Sudden
1 trial -
ET-01
Guangzhou Virotech Pharmaceutical Co.,
Transfusion Dependent Beta-Thalassaemia
1 trial -
ET-01
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Transfusion Dependent Beta-Thalassaemia
1 trial -
EUS-guided portal vein and hepatic vein aspiration
Chinese University of Hong Kong
Circulating Tumor Cell
1 trial -
EmbryoGlue® (laboratory culture medium)
United Therapeutics Europe Ltd
Infertility
1 trial -
Energy Balance
United Therapeutics Europe Ltd
Inflammation
1 trial -
Entecavir
Hospital Authority, Hong Kong
Hepatocellular Carcinoma
1 trial -
Erythromycin 4% topical gel formulation:
BRIGHT MINDS BIOSCIENCES INC.
Inflammation; Skin
1 trial -
Escitalopram Oxalate Tablets
The First People's Hospital of Lianyungang
Major Depressive Disorder
1 trial -
Essential Amino Acid Enriched Whey Protein
United Therapeutics Europe Ltd
Whole-body Protein Balance
1 trial -
Evaluation of social, cultural and behavioral factors
International Peace Maternity and Child Health Hospital
Cardio-vascular Disease
1 trial -
ExoBDNF SWP-CGPA01 (Pediococcus acidilactici)Capsules
Biotech Pharmaceutical Co.,
Cognitive Functions Perceptual Disturbances
1 trial -
Exparel block in arthroscopic shoulder surgery
Pacira Ireland Limited
Injury of Shoulder Region
1 trial -
FGFR Inhibitor, IDH1 Inhibitor, HER2 Inhibitor, PARP Inhibitor, BRAF Inhibitor, MEK Inhibitor, ICIs, EGFR-TKIs, NTRK-TKI, and et. al.
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Biliary Tract Neoplasms
1 trial -
Fecal Microbiota Transplantation (FMT)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Type 1 Diabetes
1 trial -
Fluoxetine
BRIGHT MINDS BIOSCIENCES INC.
Cocaine-Related Disorders
1 trial -
Fruit Bar
United Therapeutics Europe Ltd
Bioavailability
1 trial -
G-CSF (Granulocyte colony-stimulating factor)
The First People's Hospital of Lianyungang
Granulocyte Colony-Stimulating Factor (G-CSF) Mobilization
1 trial -
Galantamine
BRIGHT MINDS BIOSCIENCES INC.
Addiction
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources